Omnimmune Holdings, Inc.
OMMH · OTC
12/31/2009 | 12/31/2008 | 5/31/2008 | 5/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $5 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $5 | $0 | $0 |
| Operating Income | -$2 | -$5 | -$0 | -$0 |
| % Margin | – | – | -10,698.7% | – |
| Other Income/Exp. Net | $2 | -$1 | $0 | $0 |
| Pre-Tax Income | $0 | -$6 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | -10,698.7% | – |
| EPS | -0.2 | -1 | -0.01 | -0.001 |
| % Growth | 80% | -9,900% | -1,150% | – |
| EPS Diluted | -0.2 | -1 | -0.01 | -0.001 |
| Weighted Avg Shares Out | 9 | 6 | 3 | 11 |
| Weighted Avg Shares Out Dil | 9 | 6 | 3 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $7 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$5 | -$0 | -$0 |
| % Margin | – | – | -10,698.7% | – |